Cures Within Reach’s mission is to improve patient quality and length of life by leveraging the speed, safety and cost-effectiveness of testing already approved therapies for new indications that serve philanthropic and/or commercial uses, driving more treatments to more patients more quickly.

Our focus: funding the projects that, when successful, will catalyze follow-on funding and/or further trials and publications.  We focus on impacting patients with unmet medical needs, whether a repurposed treatment may have philanthropic value or commercial value.

Upcoming Events

Diversity of Clinical Trial Researchers and Patients: A Repurposing Opportunity?
November 9, 2021 (virtual): a dialogue on the dual opportunities of clinical trial diversity to impact health disparities and/or improve minority leadership in scientific research

Read about our new initiatives in 2021: efforts in Diversity, Equity & Inclusion, in Pediatrics and for Veterans/Military


Congrats to ReFRAME at Scripps Research/Calibr, CURE ID at the FDA and NCATS/NIH and Eli Lilly and Company, recipients of our 2021 Patient Impact AwardsLearn more here.

GHRA 2021 Awardees



The global healthcare community is working together in unprecedented ways to treat patients and learn from each other. There are many opportunities underway using already approved drugs in clinical trials to treat COVID19 patients, providing evidence-based medicine to clinicians.

Read more about the many clinical repurposing trials:


Resources for Repurposing in COVID19

clinical research for unsolved diseases

Diseases Researched

repurposing research grants funding

Repurposing Projects Funded


Institutions Funded


Diseases Improved


Startups with CWR Investments


Companies Commercializing CWR Projects


Millions of Dollars in Project Funding

repurposing-research-initiated -follow-on-funding supporting clinical research

Millions of Dollars in Follow-on Funding Leveraged